Actively Recruiting
Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study
Led by Technical University of Munich · Updated on 2025-01-06
63
Participants Needed
1
Research Sites
279 weeks
Total Duration
On this page
Sponsors
T
Technical University of Munich
Lead Sponsor
T
Takeda
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to gain a deeper understanding of endothelial dysfunction in patients with Fabry disease through a prospective study of the retinal microvasculature and to identify an objective, non-invasive marker to assess disease severity and cardiovascular risk in patients. The main questions addressed are: Do dynamic and static retinal vessel analysis parameters differ from those in healthy individuals? Can these parameters predict cardiovascular and/or Fabry-related events during follow-up? Do these parameters change during follow-up in patients with a non-stable disease?
CONDITIONS
Official Title
Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Diagnosis of Fabry disease by genetic testing or GB3 activity in leukocytes
- Signed informed consent form
You will not qualify if you...
- Active infection or cancer
- Surgery less than 2 weeks prior to inclusion in the study
- Known glaucoma
- Lack of capacity to give consent; lack of informed consent
- Known epilepsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of nephrology, Klinikum rechts der Isar
München, Bavaria, Germany, 81675
Actively Recruiting
Research Team
C
Christoph Schmaderer, Prof. Dr.
CONTACT
C
Claudia Regenbogen
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here